E. Kaphan

Transformation of a low-grade follicular lymphoma into a composite lymphoma combining a high-grade B-cell lymphoma and a lymphoblastic neoplasm expressing Terminal deoxynucleotidyl Transferase: a case report

R. Gressin, H. Sartelet, M. Peuchmaur, 2020, Journal of Medical Case Reports.

Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia

J. Marine, F. Rambow, J. Tamburini, 2021, Nature Cancer.

Treatment for pure red cell aplasia after major ABO‐incompatible allogeneic stem cell transplantation: a multicentre study

M. Resche-Rigon, Eléonore Kaphan, D. Amiranoff, 2021, British journal of haematology.

Late relapse after hematopoietic stem cell transplantation for acute leukemia: a retrospective study by SFGM-TC.

M. Robin, P. Chevallier, G. Guillerm, 2023, Transplantation and cellular therapy.

Ibrutinib as a treatment of hematologic autoimmune disorders in patients with indolent B‐cell lymphoma

O. Tournilhac, Eléonore Kaphan, M. Michel, 2022, European journal of haematology.

Myelodysplastic syndrome (MDS) with isolated trisomy 8: a type of MDS frequently associated with myeloproliferative features? A report by the Groupe Francophone des Myélodysplasies

E. Clappier, A. Stamatoullas, J. Vial, 2018, British journal of haematology.

Risk factors of BK viral hemorrhagic cystitis in allogenic hematopoietic stem cell transplantation

S. Bailly, Eléonore Kaphan, A. Thiébaut-Bertrand, 2021, Transplant infectious disease : an official journal of the Transplantation Society.

Impact of transfusion on survival in patients with myelodysplastic syndromes: Current knowledge, new insights and transfusion clinical practice.

Sophie Park, Eléonore Kaphan, P. Drillat, 2019, Blood reviews.

Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospital

C. Delaugerre, S. Chevret, M. Sébert, 2021, Blood Cancer Journal.

Retrospective, real‐life study of venetoclax plus azacitidine or low‐dose cytarabine in French patients with acute myeloid leukemia ineligible for intensive chemotherapy

L. Fornecker, C. Récher, K. Laribi, 2022, Cancer Medicine.